C. S. Lewin

1.0k total citations
37 papers, 660 citations indexed

About

C. S. Lewin is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, C. S. Lewin has authored 37 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 22 papers in Molecular Biology and 21 papers in Molecular Medicine. Recurrent topics in C. S. Lewin's work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Cancer therapeutics and mechanisms (21 papers) and Antibiotic Resistance in Bacteria (21 papers). C. S. Lewin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (22 papers), Cancer therapeutics and mechanisms (21 papers) and Antibiotic Resistance in Bacteria (21 papers). C. S. Lewin collaborates with scholars based in United Kingdom and Mexico. C. S. Lewin's co-authors include J. T. Smith, S. G. B. Amyes, Ian Morrissey, T. S. Hastings, Andrew C. Barnes, John R. W. Govan, Sebastian G. B. Amyes, R. A. ALLEN, R. Paton and Richard A. Allen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

C. S. Lewin

36 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. S. Lewin United Kingdom 16 335 282 250 120 104 37 660
M. Michéa-Hamzehpour Switzerland 10 335 1.0× 216 0.8× 214 0.9× 106 0.9× 74 0.7× 18 554
Sarah A. Reid‐Yu Canada 10 390 1.2× 183 0.6× 312 1.2× 155 1.3× 191 1.8× 10 839
W. TOSCH Switzerland 10 237 0.7× 165 0.6× 274 1.1× 100 0.8× 117 1.1× 17 669
Angelika Jellen-Ritter Germany 11 363 1.1× 169 0.6× 289 1.2× 99 0.8× 60 0.6× 11 710
Anne-Marie Girard United States 14 454 1.4× 350 1.2× 205 0.8× 193 1.6× 73 0.7× 16 708
Nigel A. C. Curtis United Kingdom 16 527 1.6× 336 1.2× 392 1.6× 110 0.9× 313 3.0× 25 946
K A Krebes United States 6 447 1.3× 115 0.4× 381 1.5× 138 1.1× 65 0.6× 6 852
JoAnn Dzink-Fox United States 12 259 0.8× 117 0.4× 191 0.8× 99 0.8× 70 0.7× 22 569
A J Godfrey Canada 14 232 0.7× 126 0.4× 186 0.7× 91 0.8× 52 0.5× 17 443
Toyoji Okubo Japan 11 221 0.7× 88 0.3× 292 1.2× 52 0.4× 248 2.4× 29 592

Countries citing papers authored by C. S. Lewin

Since Specialization
Citations

This map shows the geographic impact of C. S. Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. Lewin more than expected).

Fields of papers citing papers by C. S. Lewin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. Lewin. The network helps show where C. S. Lewin may publish in the future.

Co-authorship network of co-authors of C. S. Lewin

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. Lewin. A scholar is included among the top collaborators of C. S. Lewin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. Lewin. C. S. Lewin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, J. T. & C. S. Lewin. (1993). Mechanisms of antimicrobial resistance and implications for epidemiology. Veterinary Microbiology. 35(3-4). 233–242. 26 indexed citations
2.
Lewin, C. S.. (1992). Antibacterial activity of a 1,8-naphthyridine quinolone, PD131628. Journal of Medical Microbiology. 36(5). 353–357. 15 indexed citations
3.
Lewin, C. S., Ian Morrissey, & J. T. Smith. (1992). The bactericidal activity of sparfloxacin. Journal of Antimicrobial Chemotherapy. 30(5). 625–632. 18 indexed citations
4.
Lewin, C. S., Ian Morrissey, & J. T. Smith. (1991). The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment. European Journal of Clinical Microbiology & Infectious Diseases. 10(4). 240–248. 77 indexed citations
5.
Lewin, C. S., et al.. (1991). Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. Journal of Medical Microbiology. 34(1). 19–22. 26 indexed citations
6.
Lewin, C. S. & S. G. B. Amyes. (1991). The role of the SOS response in bacteria exposed to zidovudine or trimethoprim. Journal of Medical Microbiology. 34(6). 329–332. 42 indexed citations
7.
Lewin, C. S., et al.. (1991). 4-Quinolone interactions with gyrase subunit B inhibitors. Journal of Medical Microbiology. 35(6). 358–362. 6 indexed citations
8.
Barnes, Andrew C., C. S. Lewin, T. S. Hastings, & Sebastian G. B. Amyes. (1990). Cross resistance between oxytetracycline and oxolinic acid inAeromonas salmonicidaassociated with alterations in outer membrane proteins. FEMS Microbiology Letters. 72(3). 337–339. 33 indexed citations
9.
Lewin, C. S. & J. T. Smith. (1990). Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens. Journal of Medical Microbiology. 32(3). 211–214. 6 indexed citations
10.
Lewin, C. S. & S. G. B. Amyes. (1990). Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16. Journal of Medical Microbiology. 32(2). 83–86. 8 indexed citations
11.
Lewin, C. S. & S. G. B. Amyes. (1990). Bactericidal action of PD 127,391, an enhanced spectrum quinolone. Journal of Medical Microbiology. 33(1). 67–70. 7 indexed citations
12.
Lewin, C. S., R. A. ALLEN, & Sebastian G. B. Amyes. (1990). Potential mechanisms of resistance to the modern fluorinated 4-quinolones. Journal of Medical Microbiology. 31(3). 153–161. 22 indexed citations
13.
Lewin, C. S., R. A. ALLEN, & S. G. B. Amyes. (1990). Antibacterial activity of fluoroquinolones in combination with zidovudine. Journal of Medical Microbiology. 33(2). 127–131. 14 indexed citations
14.
Lewin, C. S., B. Watt, R. Paton, & Sebastian G. B. Amyes. (1990). Isolation of zidovudine resistant from AIDS patients. FEMS Microbiology Letters. 70(2). 141–143. 1 indexed citations
15.
Lewin, C. S. & S. G. B. Amyes. (1989). The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. Journal of Medical Microbiology. 30(3). 227–231. 26 indexed citations
16.
Lewin, C. S. & S. G. B. Amyes. (1989). Conditions required for the antibacterial activity of zidovudine. European Journal of Clinical Microbiology & Infectious Diseases. 8(8). 737–741. 17 indexed citations
17.
Lewin, C. S. & J. T. Smith. (1989). Interactions of the 4-quinolones with other antibacterials. Journal of Medical Microbiology. 29(3). 221–227. 12 indexed citations
18.
Lewin, C. S., S. G. B. Amyes, & J. T. Smith. (1989). Bactericidal activity of enoxacin and Lomefloxacin againstEscherichia coli KL16. European Journal of Clinical Microbiology & Infectious Diseases. 8(8). 731–733. 17 indexed citations
19.
Lewin, C. S., et al.. (1989). 4-Quinolones and the SOS response. Journal of Medical Microbiology. 29(2). 139–144. 62 indexed citations
20.
Paton, R., C. S. Lewin, J. C. Hood, & S. G. B. Amyes. (1989). Sensitivity testing of enterococci to ciprofloxacin. Journal of Antimicrobial Chemotherapy. 24(2). 265–266. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Michéa-Hamzehpour Breakdown of academic impact, for papers by Sarah A. Reid‐Yu Breakdown of academic impact, for papers by W. TOSCH Breakdown of academic impact, for papers by Angelika Jellen-Ritter Breakdown of academic impact, for papers by Anne-Marie Girard Breakdown of academic impact, for papers by Nigel A. C. Curtis Breakdown of academic impact, for papers by K A Krebes Breakdown of academic impact, for papers by JoAnn Dzink-Fox Breakdown of academic impact, for papers by A J Godfrey Breakdown of academic impact, for papers by Toyoji Okubo
Rankless by CCL
2026